text
"['\n4. 재무제표\n\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0\xa0 분 기 재 무 상 태 표\n제 30(당)기 3분기말 2020년\xa0 9월 30일 현재\n제 29(전)기\xa0 \xa0\xa0 기말 2019년 12월 31일 현재\n오렌지라이프생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0\xa0 목\n주석\n제 30(당)기 3분기말\n제 29(전)기 기말\n자\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 산\nI. 현금및상각후원가측정예치금\n4, 5, 7, 24, 39, 42\n534,391,996,433\n472,267,047,614\n\xa0 1. 현금및현금성자산\n269,338,910,326\n207,207,801,542\n\xa0 2. 상각후원가측정예치금\n265,053,086,107\n265,059,246,072\nII. 당기손익공정가치측정금융자산\n4, 5, 8, 24\n1,858,148,569,321\n1,728,293,693,006\nIII. 기타포괄손익공정가치측정금융자산\n4, 5, 9, 24, 39\n11,460,431,065,961\n10,928,362,299,279\nIV. 상각후원가측정유가증권\n4, 5, 10\n10,880,453,784,499\n10,759,325,487,499\nV. 상각후원가측정대출채권및수취채권\n4, 5, 11, 24, 39\n2,839,166,176,088\n2,970,308,321,652\n\xa0 1. 대출채권\n2,254,745,651,980\n2,355,299,250,271\n\xa0 2. 수취채권\n584,420,524,108\n615,009,071,381\nVI. 파생상품자산\n4, 5, 12, 39\n5,956,646,785\n2,267,367,114\nVII. 유형자산\n13, 39\n12,648,461,349\n8,574,968,029\nVIII.\xa0사용권자산\n14, 39\n36,390,444,969\n48,447,300,448\nIX. 무형자산\n15, 39\n67,193,228,153\n54,214,955,939\nX. 미상각신계약비\n16\n495,879,935,410\n507,204,078,383\nXI.\xa0당기법인세자산\n37\n9,090,284,395\n51,949,639,372\nXII. 기타자산\n47,126,749,831\n43,904,102,755\n\xa0 1. 재보험자산\n17\n41,314,056,437\n40,409,354,590\n\xa0 2. 순확정급여자산\n23\n-\n772,793,680\n\xa0 3. 그밖의기타자산\n18\n5,812,693,394\n2,721,954,485\nXlll. 특별계정자산\n41\n5,187,969,053,811\n5,266,240,127,319\n자\xa0 \xa0 \xa0 산\xa0 \xa0 \xa0 총\xa0 \xa0 \xa0 계\n33,434,846,397,005\n32,841,359,388,409\n부\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 채\nI. 보험계약부채\n19\n24,040,067,310,048\n23,489,001,950,253\nII. 계약자지분조정\n20\n65,793,116,952\n63,030,740,948\nIII. 파생상품부채\n5, 12, 39\n23,271,869,969\n11,615,547,189\nIV. 리스부채\n5, 14, 39\n35,102,486,351\n44,901,710,294\nV.\xa0이연법인세부채\r\n37\n441,139,490,992\n422,340,384,200\nVI. 기타부채\r\n254,594,668,475\n247,965,929,244\n\xa0 1. 지급채무\n5, 21\n98,961,157,282\n114,123,452,394\n\xa0 2. 충당부채\n22\n23,225,840,787\n20,889,833,035\n\xa0 3. 순확정급여부채\n23\n1,702,261,402\n-\n\xa0 4. 그밖의기타부채\n24, 25, 39\n130,705,409,004\n112,952,643,815\nVII. 특별계정부채\r\n41\n5,239,006,177,969\n5,375,854,820,940\n부\xa0 \xa0 \xa0 채\xa0 \xa0 \xa0 총\xa0 \xa0 \xa0 계\n30,098,975,120,756\n29,654,711,083,068\n자\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 본\nI. 자본금\n26\n82,000,000,000\n82,000,000,000\nII. 자본잉여금\n26\n488,591,962,510\n488,591,962,510\nIII. 자본조정\n26\n(24,890,664,539)\n(49,999,986,500)\nIV.\xa0기타포괄손익누계액\r\n9, 12, 26\n647,177,099,514\n623,912,476,392\nV. 이익잉여금\n26\n2,142,992,878,764\n2,042,143,852,939\n자\xa0 \xa0 \xa0 본\xa0 \xa0 \xa0 총\xa0 \xa0 \xa0 계\n3,335,871,276,249\n3,186,648,305,341\n부\xa0 채\xa0 및\xa0 자\xa0 본\xa0 총\xa0 계\n33,434,846,397,005\n32,841,359,388,409\n""별첨 주석은 본 분기재무제표의 일부입니다""\n\xa0\xa0\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 분 기 포 괄 손 익 계 산 서\n제 30(당)기 3분기 2020년 1월 1일부터 2020년 9월 30일까지\n제 29(전)기 3분기 2019년 1월 1일부터 2019년 9월 30일까지\n오렌지라이프생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0 목\n주석\n제 30(당)기 3분기\n제 29(전)기 3분기\n3개월\n누적\n3개월\n누적\nI. 영업수익\n\u3000\n1,227,330,953,237\n3,370,306,566,155\n1,130,466,048,466\n3,590,217,588,743\n\xa0 1. 보험료수익\n27\n899,827,289,893\n2,393,208,825,339\n788,865,000,235\n2,536,628,620,474\n\xa0 2. 재보험수익\n29\n31,967,726,700\n95,419,520,470\n31,638,081,808\n92,692,527,251\n\xa0 3. 이자수익\n32, 39\n208,016,587,239\n626,110,799,770\n216,600,702,368\n647,891,355,092\n\xa0 \xa0 1) 당기손익공정가치측정금융자산\n3,334,802,176\n9,748,699,599\n3,371,267,359\n10,232,039,761\n\xa0 \xa0 2) 기타포괄손익공정가치측정 및 상각후원가측정금융자산\n204,681,785,063\n616,362,100,171\n213,229,435,009\n637,659,315,331\n\xa0 4. 당기손익공정가치측정금융자산관련이익\n8, 33, 39\n36,730,767,775\n109,071,573,839\n9,553,977,484\n107,219,591,945\n\xa0 5. 당기손익공정가치측정금융자산관련이익_당기손익조정접근법\n8, 33\n(9,813,589,274)\n(43,074,709,716)\n582,123,132\n(68,267,111,325)\n\xa0 6. 기타포괄손익공정가치측정금융자산처분이익\n9, 33\n326,052,476\n22,264,803,967\n6,325,900,653\n14,296,386,253\n\xa0 7. 상각후원가측정금융자산처분이익\n33\n-\n-\n-\n76,279,505,529\n\xa0 8. 신용손실충당금환입액\n34\n122,564,255\n518,576,316\n697,777,283\n794,752,463\n\xa0 9. 파생상품관련이익\n12, 33, 39\n6,675,826,600\n5,892,689,880\n2,147,906,091\n1,688,765,454\n\xa0 10. 기타영업수익\n35, 39\n5,540,599,458\n14,278,555,560\n27,906,787,626\n46,362,288,611\n\xa0 11. 특별계정수입수수료\n41\n47,320,240,036\n144,620,824,300\n46,147,791,786\n134,630,906,996\n\xa0 12. 특별계정수익\n41\n616,888,079\n1,995,106,430\n-\n-\nII. 영업비용\n1,128,275,631,548\n3,076,472,810,316\n1,041,714,455,674\n3,298,385,349,093\n\xa0 1. 보험계약부채전입액\n19\n374,468,215,032\n550,160,657,948\n59,405,660,749\n646,052,980,187\n\xa0 2. 지급보험금\n28\n524,652,882,762\n1,887,336,310,461\n753,833,694,265\n1,919,042,103,147\n\xa0 3. 재보험비용\n29\n35,716,739,556\n107,343,550,410\n35,086,594,629\n104,739,503,935\n\xa0 4. 사업비\n16, 23, 30, 39\n91,363,813,114\n263,304,937,202\n97,009,061,778\n301,861,982,844\n\xa0 5. 신계약비상각비\n16\n62,260,364,591\n180,681,758,102\n55,622,030,301\n181,994,555,431\n\xa0 6. 재산관리비\n23, 31, 39\n5,079,309,698\n16,380,287,673\n5,850,113,465\n17,968,987,560\n\xa0 7. 이자비용\n32\n451,407,082\n1,431,794,493\n560,684,861\n1,373,970,656\n\xa0 8. 당기손익공정가치측정금융자산관련손실\n8, 33\n(17,383,992,870)\n25,059,160,337\n12,074,651,763\n22,655,781,120\n\xa0 9. 당기손익공정가치측정금융자산관련손실_당기손익조정접근법\n8, 33\n17,980,799,900\n(23,329,022,237)\n(663,959,185)\n58,774,088,685\n\xa0 10. 기타포괄손익공정가치측정금융자산처분손실\n9, 33\n389,656,453\n7,502,127,851\n-\n-\n\xa0 11. 신용손실충당금전입액\n34\n510,209,103\n691,285,777\n241,038,968\n880,122,187\n\xa0 12. 파생상품관련손실\n12, 33, 39\n131,265,458\n14,176,419,154\n12,284,122,364\n22,328,379,930\n\xa0 13. 기타영업비용\n35\n23,990,306,360\n17,336,394,755\n7,079,973,793\n10,870,173,560\n\xa0 14. 특별계정지급수수료\n41\n8,047,767,230\n26,402,041,960\n3,330,787,923\n9,842,719,851\n\xa0 15. 특별계정비용\n41\n616,888,079\n1,995,106,430\n-\n-\nIII. 영업이익\n99,055,321,689\n293,833,755,839\n88,751,592,792\n291,832,239,650\nIV. 영업외비용\n36\n(8,594,231)\n(5,722,871,099)\n(1,081,751,538)\n(3,015,345,368)\nV. 법인세비용차감전순이익\n99,046,727,458\n288,110,884,740\n87,669,841,254\n288,816,894,282\nVI. 법인세비용\n37\n23,198,947,464\n74,806,767,456\n23,278,342,058\n77,249,104,773\nVII. 분기순이익\n75,847,779,994\n213,304,117,284\n64,391,499,196\n211,567,789,509\nVIII. 기타포괄손익\n9, 12, 26, 41\n15,323,314,825\n15,478,125,563\n55,606,764,842\n309,842,848,531\n\xa0 1. 후속적으로 당기손익으로 재분류되는 항목\n19,865,286,442\n69,670,354,330\n55,606,764,842\n310,528,059,010\n\xa0 \xa0 가. 기타포괄손익공정가치측정금융자산평가이익\n4,004,680,427\n61,072,888,725\n58,558,875,555\n230,873,883,272\n\xa0 \xa0 나. 당기손익공정가치측정금융자산관련이익(손실)_당기손익조정접근법\r\n18,536,481,161\n14,061,715,950\n(603,682,509)\n89,028,417,352\n\xa0 \xa0 다. 현금흐름위험회피파생상품평가손실\n(3,070,047,753)\n(6,187,541,804)\n(2,348,428,204)\n(9,374,241,614)\n\xa0 \xa0 라. 특별계정기타포괄이익\n394,172,607\n723,291,459\n-\n-\n\xa0 2. 당기손익으로 재분류되지 않는 항목\n(4,541,971,617)\n(54,192,228,767)\n-\n(685,210,479)\n\xa0 \xa0 가. 확정급여제도의 재측정요소\n-\n26,405,972\n-\n(685,210,479)\n\xa0 \xa0 나. 기타포괄손익공정가치측정금융자산평가이익(손실)\n3,244,525,942\n(46,432,137,180)\n-\n-\n\xa0 \xa0 다. 기타포괄손익공정가치측정금융자산처분손실\n(7,786,497,559)\n(7,786,497,559)\n-\n-\nIX. 분기총포괄손익\n91,171,094,819\n228,782,242,847\n119,998,264,038\n521,410,638,040\nX. 주당이익\n40\n\xa0 \xa0 기본 및 희석 주당이익\n925\n2,612\n799\n2,606\n""별첨 주석은 본 분기재무제표의 일부입니다""\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0\xa0 \xa0 \xa0\xa0 분 기 자 본 변 동 표\n제 30(당)기 3분기 2020년 1월 1일부터 2020년 9월 30일까지\n제 29(전)기 3분기 2019년 1월 1일부터 2019년 9월 30일까지\n오렌지라이프생명보험주식회사\n(단위 : 원)\n구\xa0 분\n자본금\n자본잉여금\n자본조정\n기타포괄손익누계액\n이익잉여금\n총\xa0\xa0 계\n2019년 1월 1일(전기초)\n82,000,000,000\n488,591,962,510\n-\n1,230,074,879,126\n1,971,779,020,619\n3,772,445,862,255\n\xa0기업회계기준서 제1109호 최초 적용에 따른 조정\xa0\n-\n-\n-\n(768,216,762,696)\n(5,066,651,698)\n(773,283,414,394)\n2019년\xa0 1월 1일(전기초)\n82,000,000,000\n488,591,962,510\n-\n461,858,116,430\n1,966,712,368,921\n2,999,162,447,861\n\xa0 분기순이익\n-\n-\n-\n-\n211,567,789,509\n211,567,789,509\n\xa0 기타포괄손익:\n\xa0\xa0 기타포괄손익공정가치측정금융자산\xa0\xa0 평가이익\n-\n-\n-\n230,873,883,272\n-\n230,873,883,272\n\xa0\xa0 당기손익공정가치측정금융자산관련\xa0\xa0 이익_당기손익조정접근법\n-\n-\n-\n89,028,417,352\n-\n89,028,417,352\n\xa0\xa0 현금흐름위험회피파생상품평가손실\n-\n-\n-\n(9,374,241,614)\n-\n(9,374,241,614)\n\xa0\xa0 확정급여제도의 재측정요소\n-\n-\n-\n(685,210,479)\n-\n(685,210,479)\n소\xa0 계\n-\n-\n-\n309,842,848,531\n-\n309,842,848,531\n\xa0분기총포괄손익\n-\n-\n-\n309,842,848,531\n211,567,789,509\n521,410,638,040\n\xa0배당지급액\n-\n-\n-\n-\n(196,024,000,000)\n(196,024,000,000)\n\xa0자기주식취득\n-\n(49,999,986,500)\n-\n-\n(49,999,986,500)\n2019년 9월 30일(전분기말)\n82,000,000,000\n488,591,962,510\n(49,999,986,500)\n771,700,964,961\n1,982,256,158,430\n3,274,549,099,401\n2020년\xa0 1월 1일(당기초)\n82,000,000,000\n488,591,962,510\n(49,999,986,500)\n623,912,476,392\n2,042,143,852,939\n3,186,648,305,341\n\xa0 분기순이익\n-\n-\n-\n-\n213,304,117,284\n213,304,117,284\n\xa0 기타포괄손익:\n\xa0\xa0 기타포괄손익공정가치측정금융자산\xa0 \xa0\xa0 \xa0\xa0 평가이익\n-\n-\n-\n14,640,751,545\n-\n14,640,751,545\n\xa0\xa0 기타포괄손익공정가치측정금융자산\xa0 \xa0\xa0 \xa0\xa0 처분손실\n-\n-\n-\n(7,786,497,559)\n-\n(7,786,497,559)\n\xa0\xa0 당기손익공정가치측정금융자산관련\xa0 \xa0\xa0 \xa0\xa0 손실_당기손익조정접근법\n-\n-\n-\n14,061,715,950\n-\n14,061,715,950\n\xa0\xa0 현금흐름위험회피파생상품평가손실\n-\n-\n-\n(6,187,541,804)\n-\n(6,187,541,804)\n\xa0\xa0 확정급여제도의 재측정요소\n-\n-\n-\n26,405,972\n-\n26,405,972\n\xa0\xa0 특별계정기타포괄이익\n-\n-\n-\n723,291,459\n-\n723,291,459\n소\xa0 계\n-\n-\n-\n15,478,125,563\n-\n15,478,125,563\n\xa0분기총포괄손익\n-\n-\n-\n15,478,125,563\n213,304,117,284\xa0\n228,782,242,847\n\xa0배당지급액\n-\n-\n-\n-\n(104,668,593,900)\n(104,668,593,900)\n\xa0자기주식취득\n-\n-\n(235,872,112,385)\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\xa0\n(235,872,112,385)\n\xa0자기주식처분\n-\n-\n285,872,098,885\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\xa0\n285,872,098,885\n\xa0기타자본조정\n-\n-\n(24,890,664,539)\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\xa0\n(24,890,664,539)\n\xa0기타포괄손익 이익잉여금 재분류\n-\n-\n-\n7,786,497,559\n(7,786,497,559)\n-\n2020년 9월 30일(당분기말)\n82,000,000,000\n488,591,962,510\n(24,890,664,539)\n647,177,099,514\n2,142,992,878,764\xa0\n3,335,871,276,249\n""별첨 주석은 본 분기재무제표의 일부입니다""\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 분 기 현 금 흐 름 표\n제 30(당)기 3분기 2020년 1월 1일부터 2020년 9월 30일까지\n제 29(전)기 3분기 2019년 1월 1일부터 2019년 9월 30일까지\n오렌지라이프생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0 목\n제 30(당)기 3분기\n제 29(전)기 3분기\nI. 영업활동으로 인한 현금흐름\n\u3000\n803,307,066,036\n1,102,913,992,982\n1. 법인세비용차감전순이익\n288,110,884,740\n\u3000\n288,816,894,282\n2. 조정사항\n(624,679,005,277)\n(646,517,384,436)\n\xa0 \xa0 이자수익\n(626,110,799,770)\n(647,891,355,092)\n\xa0 \xa0 이자비용\n1,431,794,493\n1,373,970,656\n3. 현금의유출이없는비용등의가산\n785,035,140,072\n963,980,676,481\n\u3000\n\xa0 \xa0 보험계약부채전입액\n550,160,657,948\n646,052,980,187\n\xa0 \xa0 당기손익공정가치측정금융자산관련손실\n25,059,160,337\n22,655,781,120\n\xa0 \xa0 당기손익공정가치측정금융자산관련손실_\n\xa0 \xa0 당기손익조정접근법\n(23,329,022,237)\n58,774,088,685\n\xa0 \xa0 기타포괄손익공정가치측정금융자산처분손실\n7,502,127,851\n-\n\xa0 \xa0 파생상품평가손실\n1,835,760,498\n6,042,705,825\n\xa0 \xa0 파생상품거래손실\n10,128,444,156\n15,835,375,044\n\xa0 \xa0 외화환산손실\n1,060,736,508\n2,208,448,706\n\xa0 \xa0 퇴직급여\n1,132,410,003\n1,145,266,247\n\xa0 \xa0 신계약비상각비\n180,681,758,102\n181,994,555,431\n\xa0 \xa0 유형자산감가상각비\n2,623,143,533\n3,288,864,252\n\xa0 \xa0 사용권자산감가상각비\n15,215,834,536\n18,035,423,731\n\xa0 \xa0 무형자산상각비\n11,558,380,540\n6,748,032,598\n\xa0 \xa0 신용손실충당금전입액\n691,285,777\n880,122,187\n\xa0 \xa0 유형자산처분손실\n300,902,494\n23,993,943\n\xa0 \xa0 리스사용권자산해지손실\n179,872,236\n19,072,001\n\xa0 \xa0 복구충당부채전입및환입액\n139,487,059\n275,966,524\n\xa0 \xa0 특별계정수수료\n79,416,731\n-\n\xa0 \xa0 잡손실\n14,784,000\n-\n4. 현금의유입이없는수익등의차감\n(67,022,318,120)\n(99,844,510,923)\n\u3000\n\xa0 \xa0 당기손익공정가치측정금융자산관련이익\n71,255,245,368\n107,219,591,945\n\xa0 \xa0 당기손익공정가치측정금융자산관련이익_\n\xa0 \xa0 당기손익조정접근법\n(43,074,709,716)\n(68,267,111,325)\n\xa0 \xa0 파생상품평가이익\n5,117,240,210\n-\n\xa0 \xa0 파생상품거래이익\n406,815,259\n1,688,765,454\n\xa0 \xa0 외화환산이익\n7,644,383,831\n31,881,530,640\n\xa0 \xa0 기타포괄손익공정가치측정금융자산처분이익\n22,264,803,967\n14,296,386,253\n\xa0 \xa0 신용손실충당금환입액\n518,576,316\n794,752,463\n\xa0 \xa0 유형자산처분이익\n-\n3,990,000\n\xa0 \xa0 리스사용권자산해지이익\n16,492,987\n7,721,881\n\xa0 \xa0 외환차손익\n2,865,688,511\n11,899,514,916\n\u3000\n\xa0 \xa0 잡이익\n7,781,387\n319,368,696\n5. 자산부채의증감\n(100,879,180,847)\n112,976,540,515\n\xa0 \xa0 상각후원가측정예치금\n6,159,965\n119,252,500,000\n\xa0 \xa0 상각후원가측정대출채권및수취채권\n114,413,048,813\n282,786,095,573\n\xa0 \xa0 파생상품\n1,884,303,520\n(320,636,139)\n\xa0 \xa0 미상각신계약비\n(169,357,615,129)\n(176,962,449,930)\n\xa0 \xa0 그밖의 기타자산\n(3,090,738,909)\n(3,462,600,829)\n\xa0 \xa0 특별계정자산\n79,189,300,169\n(35,365,134,116)\n\xa0 \xa0 지급채무\n(15,316,846,120)\n(86,866,604,213)\n\xa0 \xa0 충당부채\n1,956,149,231\n121,040,350\n\xa0 \xa0 확정급여채무\n1,359,091,758\n216,524,531\n\xa0 \xa0 그밖의 기타부채\n24,926,608,826\n(26,960,494,173)\n\xa0 \xa0 특별계정부채\n(136,848,642,971)\n40,538,299,461\n\xa06. 이자수취액\n543,574,893,783\n533,423,090,571\n\xa07. 이자지급액\n(829,453,898)\n(789,972,719)\n\xa08. 법인세납부\n(20,003,894,417)\n(49,131,340,789)\nII. 투자활동으로 인한 현금흐름\n(385,127,710,670)\n(713,002,252,171)\n\xa01. 투자활동으로 인한 현금유입액\n2,846,580,688,550\n1,344,273,037,830\n\xa0 \xa0\xa0 당기손익공정가치측정금융자산 감소\n609,121,824,744\n186,824,003,311\n\xa0 \xa0\xa0 기타포괄손익공정가치측정금융자산 감소\n2,214,700,383,937\n1,149,371,685,611\n\xa0 \xa0\xa0 상각후원가측정금융자산의 감소\n22,046,828,359\n5,635,570,146\n\xa0 \xa0\xa0 위험회피활동으로 인한 현금유입\n711,651,510\n2,326,800,132\n\xa0 \xa0\xa0 유형자산의 처분\n-\n4,000,000\n\xa0 \xa0\xa0 사용권자산의 처분\n-\n110,978,630\n\xa02. 투자활동으로 인한 현금유출액\n(3,231,708,399,220)\n(2,057,275,290,001)\n\xa0 \xa0\xa0 당기손익공정가치측정금융자산 취득\n680,501,194,622\n122,234,565,172\n\xa0 \xa0\xa0 기타포괄손익공정가치측정금융자산의 취득\n2,481,566,375,005\n1,278,433,521,822\n\xa0 \xa0\xa0 상각후원가측정금융자산의 취득\n18,991,670,837\n617,333,582,547\n\xa0 \xa0\xa0 위험회피활동으로 인한 현금유출\n12,204,231,254\n19,182,848,194\n\xa0 \xa0\xa0 유형자산의 취득\n7,157,842,947\n2,903,802,800\n\xa0 \xa0\xa0 무형자산의 취득\n31,287,084,555\n17,186,969,466\nIII. 재무활동으로 인한 현금흐름\n(355,929,951,376)\n(262,579,639,492)\n\xa01. 재무활동으로 인한 현금유입액\n-\n-\n\xa02. 재무활동으로 인한 현금유출액\n(355,929,951,376)\n(262,579,639,492)\n\xa0 \xa0\xa0 리스부채의 감소\n14,036,312,722\n16,555,652,992\n\xa0 \xa0\xa0 자기주식의 취득\n235,872,112,385\n49,999,986,500\n\xa0 \xa0\xa0 배당금 지급\n104,668,593,900\n196,024,000,000\n\xa0 \xa0\xa0 자기주식교환\n1,352,932,369\n-\nIV. 현금및현금성자산의 증가 (I+II+III)\n62,249,403,990\n127,332,101,319\nV. 외화환산으로 인한 현금및현금성자산 변동\n(118,295,206)\n3,074,737,207\nVI. 기초의 현금및현금성자산\n207,207,801,542\n154,754,409,500\nⅦ. 분기말의 현금및현금성자산\n269,338,910,326\n285,161,248,026\n""별첨 주석은 본 분기재무제표의 일부입니다""\n']"
